abstract |
The present invention is a compound of formula I, a pharmaceutically acceptable thereof, which may be useful for treating a disease or condition mediated by MMPs, agrecanase, ADMP, LpxC, ADAMs, TACE, TNF-α, or a combination thereof. To the salts, solvates or isomers thereof.n n n Formula I |